Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Liabilities" stands at 91.08 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Total Liabilities" stands at 91.08 Billion USD. This represents an increase of 10.31 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 48.62 percent compared to the value the year prior.
The 1 year change in percent is 48.62.
The 3 year change in percent is 144.22.
The 5 year change in percent is 133.85.
The 10 year change in percent is 332.42.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Total Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Liabilities | 280,205,508,085.11 |
![]() | Novartis AG - Total Liabilities | 255,096,620,580.91 |